熱門資訊> 正文
摩根大通暂停评级，Wave Life Sciences股价上涨
2025-08-16 00:43
- WaVe生命科學(WVE) 0
- 摩根大通(JPM) 0
- 纳比特(NA) 0
- Wave Life Sciences (NASDAQ:WVE) quickly hit highs of the day, rising 5%, after JPMorgan suspended its rating, price target, and estimates on the company.
- Some investors may be speculating that JPMorgan suspended its rating because it's advising the company on some type of transaction.
More on Wave Life Sciences
- Wave Life Sciences Ltd. (WVE) Q2 2025 Earnings Call Transcript
- Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months
- Wave Life Sciences: Speculative, But Promising
- Wave Life Sciences is a new Buy at Canaccord Genuity on near-term catalysts
- Wave Life Sciences signals key Q3 and Q4 data catalysts as INHBE and AATD programs advance
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
